Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Morten Sogaard
PSD | President | - | 01/05/22 |
Jason Schwartz
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
David Smethurst
LAW | General Counsel | - | 01/08/21 |
Fulvio Mavilio
PRN | Corporate Officer/Principal | - | 18/07/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Kush Parmar
BRD | Director/Board Member | 42 | 01/07/13 |
Alan Beggs
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 45 783 265 | 42 304 829 ( 92,40 %) | 0 | 92,40 % |
Coordinate società
Astellas Gene Therapies, Inc.
480 Forbes Boulevard
94080, South San Francisco
+415 818 1001
http://www.astellasgenetherapies.com![Indirizzo Audentes Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/29774501.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+15,58% | 122 Mrd | |
+16,60% | 113 Mrd | |
+17,55% | 26,22 Mrd | |
-24,33% | 19,01 Mrd | |
-19,14% | 15,71 Mrd | |
-17,95% | 15,22 Mrd | |
-46,81% | 14,72 Mrd | |
+58,78% | 14,58 Mrd | |
+4,91% | 13,84 Mrd |